SCHEMBL9364653

SCHEMBL9364653

CCC(=O)C(=O)Nc1ccc(C(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.58
KMT2A Q03164 3/20 0.57
PKM P14618 2/20 0.57
MEN1 O00255 2/20 0.57
MAPT P10636 7/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPK1 P28482 4/20 0.54
GAA P10253 2/20 0.53
STAT3 P40763 1/20 0.53
THRB P10828 1/20 0.52
AKR1B1 P15121 1/20 0.51
AKR1C4 P17516 1/20 0.51
AKR1C3 P42330 1/20 0.51
AKR1C2 P52895 1/20 0.51
AKR1C1 Q04828 1/20 0.51
POLB P06746 1/20 0.51
HPD P32754 1/20 0.51
HTT P42858 3/20 0.50
LMNA P02545 2/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364666 0.90 AKR1B1 (0.53) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL7976022 0.85 GPR35 (0.57) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL16739563 0.83 KCNMA1 (0.63) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL11005634 0.83 KCNMA1 (0.66) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL8135625 0.82 KCNMA1 (0.55) KCNMA1KMT2AMEN1MAPTALDH1A1
SCHEMBL5606246 0.82 KCNMA1 (0.64) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL27672851 0.81 KCNMA1 (0.60) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL29659895 0.81 KCNMA1 (0.63) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL22262383 0.81 KCNMA1 (0.63) KCNMA1KMT2APKMMEN1MAPT
SCHEMBL9364781 0.81 ALDH1A1 (0.59) KCNMA1KMT2AMAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed